Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 344

1.

Quantity and quality of nucleic acids extracted from archival formalin fixed paraffin embedded prostate biopsies.

Carlsson J, Davidsson S, Fridfeldt J, Giunchi F, Fiano V, Grasso C, Zelic R, Richiardi L, Andrén O, Pettersson A, Fiorentino M, Akre O.

BMC Med Res Methodol. 2018 Dec 5;18(1):161. doi: 10.1186/s12874-018-0628-1.

2.

Persistent Mullerian duct syndrome: Report of two cases with phenotypical immunohistochemical profiling.

Ambrosi F, Fiorentino M, Chessa F, Brunocilla E, D'Errico A, Bertuzzo RV, Giunchi F.

Urologia. 2018 Nov;85(4):177-181. doi: 10.1177/0391560317749426. Epub 2018 Mar 28.

PMID:
30426882
3.

Unusual metastatic localization to the kidney of basaloid squamous cell carcinoma of the oropharynx.

Ricci C, Rossi MS, De Stefano R, Fiorentino M, Vasuri F.

Urologia. 2018 Nov;85(4):182-185. doi: 10.1177/0391560317749423. Epub 2018 Mar 23.

PMID:
30426881
4.

Emerging Molecular Technologies in Genitourinary Tumors.

Giunchi F, Cimadamore A, Fiorentino M.

Front Oncol. 2018 Oct 30;8:489. doi: 10.3389/fonc.2018.00489. eCollection 2018. No abstract available.

5.

A Prospective Study of the Association between Physical Activity and Risk of Prostate Cancer Defined by Clinical Features and TMPRSS2:ERG.

Pernar CH, Ebot EM, Pettersson A, Graff RE, Giunchi F, Ahearn TU, Gonzalez-Feliciano AG, Markt SC, Wilson KM, Stopsack KH, Gazeeva E, Lis RT, Parmigiani G, Rimm EB, Finn SP, Giovannucci EL, Fiorentino M, Mucci LA.

Eur Urol. 2018 Oct 6. pii: S0302-2838(18)30730-9. doi: 10.1016/j.eururo.2018.09.041. [Epub ahead of print]

PMID:
30301696
6.

MYC Amplification as a Potential Mechanism of Primary Resistance to Crizotinib in ALK-Rearranged Non-Small Cell Lung Cancer: A Brief Report.

Rihawi K, Alfieri R, Fiorentino M, Fontana F, Capizzi E, Cavazzoni A, Terracciano M, La Monica S, Ferrarini A, Buson G, Petronini PG, Ardizzoni A.

Transl Oncol. 2018 Oct 2;12(1):116-121. doi: 10.1016/j.tranon.2018.09.013. [Epub ahead of print]

7.

Predictive markers in lung cancer: a few hints for the practicing pathologist.

Barbareschi M, Barberis M, Buttitta F, Doglioni C, Fiorentino M, Fontanini G, Franco R, Marchetti A, Rossi G, Troncone G.

Pathologica. 2018 Mar;110(1):29-38. Review.

PMID:
30259911
8.

Genomic profiles of primary and metastatic esophageal adenocarcinoma identified via digital sorting of pure cell populations: results from a case report.

Isidori F, Malvi D, Fittipaldi S, Forcato C, Bozzarelli I, Sala C, Raulli G, D'Errico A, Fiorentino M, Seri M, Krishnadath KK, Bonora E, Mattioli S; EAC-BAGH group.

BMC Cancer. 2018 Sep 12;18(1):889. doi: 10.1186/s12885-018-4789-4.

9.

Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal disease.

Ahearn TU, Peisch S, Pettersson A, Ebot EM, Zhou K, Graff RE, Sinnott JA, Fazli L, Judson GL, Bismar TA, Rider JR, Gerke T, Chan JM, Fiorentino M, Flavin R, Sesso HD, Finn S, Giovannucci EL, Gleave M, Loda M, Li Z, Pollak M, Mucci LA; Transdisciplinary Prostate Cancer Partnership (ToPCaP).

Carcinogenesis. 2018 Aug 24. doi: 10.1093/carcin/bgy112. [Epub ahead of print]

PMID:
30165429
10.

Biological issues with cabozantinib in bone metastatic renal cell carcinoma and castration-resistant prostate cancer.

Di Nunno V, Cimadamore A, Santoni M, Scarpelli M, Fiorentino M, Ciccarese C, Iacovelli R, Cheng L, Lopez-Beltran A, Massari F, Montironi R.

Future Oncol. 2018 Oct;14(25):2559-2564. doi: 10.2217/fon-2018-0158. Epub 2018 Aug 24. No abstract available.

11.

Corpora amylacea in prostatectomy tissue and associations with molecular, histological, and lifestyle factors.

DuPre NC, Flavin R, Sfanos KS, Unger RH, To S, Gazeeva E, Fiorentino M, De Marzo AM, Rider JR, Mucci LA; Transdisciplinary Prostate Cancer Partnership(ToPCaP).

Prostate. 2018 Nov;78(15):1172-1180. doi: 10.1002/pros.23692. Epub 2018 Jul 15.

PMID:
30009541
12.

Role of microRNAs in the main molecular pathways of hepatocellular carcinoma.

Vasuri F, Visani M, Acquaviva G, Brand T, Fiorentino M, Pession A, Tallini G, D'Errico A, de Biase D.

World J Gastroenterol. 2018 Jul 7;24(25):2647-2660. doi: 10.3748/wjg.v24.i25.2647. Review.

13.

Clinical outcome and time trends of surgically treated renal cell carcinoma between 1986 and 2010: results from a single centre in Sweden.

Grabowska B, Ulvskog E, Carlsson J, Fiorentino M, Giunchi F, Lindblad P, Sundqvist P.

Scand J Urol. 2018 Jun;52(3):206-212. doi: 10.1080/21681805.2018.1430706. Epub 2018 Jul 4.

PMID:
29972347
14.

A case of complete response to nivolumab after long-term progression-free survival with tyrosine kinase inhibitor.

Mollica V, Di Nunno V, Corcioni B, Fiorentino M, Nobili E, Schiavina R, Golfieri R, Brunocilla E, Ardizzoni A, Massari F.

Anticancer Drugs. 2018 Oct;29(9):911-913. doi: 10.1097/CAD.0000000000000663.

PMID:
29916898
15.

Biomarkers of aggressiveness in genitourinary tumors with emphasis on kidney, bladder, and prostate cancer.

Cimadamore A, Gasparrini S, Santoni M, Cheng L, Lopez-Beltran A, Battelli N, Massari F, Giunchi F, Fiorentino M, Scarpelli M, Montironi R.

Expert Rev Mol Diagn. 2018 Jul;18(7):645-655. doi: 10.1080/14737159.2018.1490179. Epub 2018 Jun 29.

PMID:
29912582
16.

Long-term survival in patients with septic acute kidney injury is strongly influenced by renal recovery.

Fiorentino M, Tohme FA, Wang S, Murugan R, Angus DC, Kellum JA.

PLoS One. 2018 Jun 5;13(6):e0198269. doi: 10.1371/journal.pone.0198269. eCollection 2018.

17.

Preoperative Staging With 11C-Choline PET/CT Is Adequately Accurate in Patients With Very High-Risk Prostate Cancer.

Schiavina R, Bianchi L, Mineo Bianchi F, Borghesi M, Pultrone CV, Dababneh H, Castellucci P, Ceci F, Nanni C, Gaudiano C, Fiorentino M, Porreca A, Chessa F, Minervini A, Fanti S, Brunocilla E.

Clin Genitourin Cancer. 2018 Aug;16(4):305-312.e1. doi: 10.1016/j.clgc.2018.05.010. Epub 2018 May 30.

PMID:
29859737
18.

Clinical management of a pituitary gland metastasis from clear cell renal cell carcinoma.

Di Nunno V, Mollica V, Corcioni B, Fiorentino M, Nobili E, Schiavina R, Golfieri R, Brunocilla E, Ardizzoni A, Massari F.

Anticancer Drugs. 2018 Aug;29(7):710-715. doi: 10.1097/CAD.0000000000000644.

PMID:
29846249
19.

Improving Translation from Preclinical Studies to Clinical Trials in Acute Kidney Injury.

Fiorentino M, Kellum JA.

Nephron. 2018;140(2):81-85. doi: 10.1159/000489576. Epub 2018 May 23.

20.

Cerebral perfusion issues in type A aortic dissection.

Pacini D, Murana G, Di Marco L, Berardi M, Mariani C, Coppola G, Fiorentino M, Leone A, Di Bartolomeo R.

J Vis Surg. 2018 Apr 24;4:77. doi: 10.21037/jovs.2018.03.20. eCollection 2018. Review.

Supplemental Content

Loading ...
Support Center